MA56391A - Agonistes du récepteur du peptide de type glucagon 1 - Google Patents

Agonistes du récepteur du peptide de type glucagon 1

Info

Publication number
MA56391A
MA56391A MA056391A MA56391A MA56391A MA 56391 A MA56391 A MA 56391A MA 056391 A MA056391 A MA 056391A MA 56391 A MA56391 A MA 56391A MA 56391 A MA56391 A MA 56391A
Authority
MA
Morocco
Prior art keywords
glucagon
peptide
receptor agonists
agonists
receptor
Prior art date
Application number
MA056391A
Other languages
English (en)
Other versions
MA56391B1 (fr
Inventor
David Andrew Coates
Todd Fields
Joseph Daniel Ho
Fucheng Qu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2020/038617 external-priority patent/WO2020263695A1/fr
Publication of MA56391A publication Critical patent/MA56391A/fr
Publication of MA56391B1 publication Critical patent/MA56391B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA56391A 2019-06-28 2020-06-19 Agonistes du récepteur du peptide de type glucagon 1 MA56391B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962868117P 2019-06-28 2019-06-28
PCT/US2020/038617 WO2020263695A1 (fr) 2019-06-28 2020-06-19 Agonistes du récepteur du peptide de type glucagon 1

Publications (2)

Publication Number Publication Date
MA56391A true MA56391A (fr) 2022-05-04
MA56391B1 MA56391B1 (fr) 2023-11-30

Family

ID=80781601

Family Applications (1)

Application Number Title Priority Date Filing Date
MA56391A MA56391B1 (fr) 2019-06-28 2020-06-19 Agonistes du récepteur du peptide de type glucagon 1

Country Status (2)

Country Link
AR (1) AR119173A1 (fr)
MA (1) MA56391B1 (fr)

Also Published As

Publication number Publication date
AR119173A1 (es) 2021-12-01
MA56391B1 (fr) 2023-11-30

Similar Documents

Publication Publication Date Title
IL288479A (en) Glucagon-like peptide 1 receptor agonists
EP4069686A4 (fr) Agoniste du récepteur glp-1
HUE058044T2 (hu) Fenilpirrolidinon-formil peptid 2 receptor agonisták
DK4058445T3 (da) Glp-1-receptoragonist og anvendelse deraf
DK3806855T5 (da) GLP-1-receptoragonister og anvendelser deraf
DK3806955T3 (da) GLP-1-receptoragonister og anvendelser deraf
EP3864013A4 (fr) Agonistes du récepteur des hormones thyroïdiennes
DK3810201T3 (da) GIP/GLP1-agonist-sammensætninger
DK4034555T3 (da) Dap10/dap12-fusionspolypeptider
IL288536A (en) Il2 agonists
EP3871694A4 (fr) Composition
EP3406264A4 (fr) Composition comprenant un agoniste du récepteur de glp-1 et un agoniste du récepteur du glucagon et application associée
EP3851448A4 (fr) Peptide récepteur anti-érythropoïétine
EP3549948A4 (fr) Peptide agoniste pour récepteur d'adiponectine
EP4073086A4 (fr) Nouvelles hormones peptidiques